Recipharm Advanced Bio

ABOUT RECIPHARM ADVANCED BIO

Recipharm Advanced Bio, a division of Recipharm, is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialize advanced therapy medicinal products (ATMPs). Recipharm Advanced Bio’s specialized CDMO capabilities include pre-clinical to clinical development and manufacturing and commercial production of novel biological modalities encompassing live viruses and viral vectors live-biotherapeutic products, nucleic acid based mRNA and plasmid DNA.

Led by an agile management team and robust technical experts with a proven track record in both process development and contract manufacturing, Recipharm Advanced Bio offers the knowledge and resources necessary to help customers deliver promising new therapies to critical patient needs across the world and to advance the future of global health.